Investor Relations

In the first six months of the financial year 2020, HAEMATO AG, Berlin (ISIN: DE0006190705) achieved an IFRS group sales of EUR 115.8 million (previous year: EUR 94.0 million). This corresponds to an increase in sales of almost 23.19 % compared to the same period of the previous year. The result from ordinary business activities (EBITDA) of EUR 2,066 thousand (previous year: EUR 1,675 thousand) was also increased by approx. 23 % compared to the same period of the previous year.

The operating result (EBIT) of EUR 1,230 thousand (previous year: EUR 708 thousand) increased significantly by 73.82 % compared to the same period in the previous year. The noncash depreciation of EUR -3,403 thousand on the fair value of the financial assets led to a net loss of EUR 2,820 thousand as of June 30, 2020.

The equity ratio was 61.3 % as of 30.06.2020. This was thus 5.1 % higher than the equity ratio of 56.17 % as of 31.12.2019.